These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8397479)

  • 1. Superantigens and their potential role in human disease.
    Kotzin BL; Leung DY; Kappler J; Marrack P
    Adv Immunol; 1993; 54():99-166. PubMed ID: 8397479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
    Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
    J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.
    Marrack P; Winslow GM; Choi Y; Scherer M; Pullen A; White J; Kappler JW
    Immunol Rev; 1993 Feb; 131():79-92. PubMed ID: 8387458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
    Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
    J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigens of mouse mammary tumor virus.
    Acha-Orbea H; MacDonald HR
    Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of superantigens in the immunobiology of retroviruses.
    Huber BT; Beutner U; Subramanyam M
    Ciba Found Symp; 1994; 187():132-40; discussion 140-3. PubMed ID: 7796668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMTV superantigens coerce an unconventional topology between the TCR and MHC class II.
    Fortin JS; Genève L; Gauthier C; Shoukry NH; Azar GA; Younes S; Yassine-Diab B; Sékaly RP; Fremont DH; Thibodeau J
    J Immunol; 2014 Feb; 192(4):1896-906. PubMed ID: 24453254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigens: structure and relevance to human disease.
    Johnson HM; Torres BA; Soos JM
    Proc Soc Exp Biol Med; 1996 Jun; 212(2):99-109. PubMed ID: 8650257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigens.
    Fleischer B
    Curr Opin Immunol; 1992 Aug; 4(4):392-5. PubMed ID: 1388839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of Mls-1.
    Beutner U; Rudy C; Huber BT
    Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral superantigens].
    Us D
    Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.
    Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT
    J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.